Dr. Susan Welsh is the Chief Safety Officer and Head of Global Pharmacovigilance & Epidemiology at Sanofi. She has 27 years of broad management experience in both R&D and commercial sectors of the global pharmaceutical industry, preceded by 10 years experience in direct patient care as a physician.
Susan has 15 years’ experience in PV/Risk Management, overseeing drug safety directly or managing safety as part of clinical development/medical affairs roles. Prior to joining Sanofi, Susan held global leadership roles in PV at BMS and Pfizer. During her years at BMS and Pfizer, she has had increasing PV responsibilities for a broad array of small molecules and biologics across the product lifecycle. Susan has worked in numerous therapeutic and product areas e.g. oncology, haematology, immuno-therapies, rheumatology, genetically defined diseases, neuroscience, vaccines, generics, over-the-counter and mature products.
Susan received her Medical and Bachelor of Science degrees from the University of Leeds, UK. She earned a Master's in Information Management from Washington University, St. Louis and an MBA from the University of California at Berkeley, USA. She is a Fellow of the Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians (UK), a Member of the Royal College of General Practitioners (UK), a Member of the Royal College of Psychiatrists (UK), a Diplomat of the Royal College of Obstetricians and Gynaecologists (UK) and Member of the American College of Physicians.
Before joining industry, Susan practiced medicine for 10 years in Great Britain. During this time she served for 6 years as an officer in Britain's Royal Air Force.
